Switch from indinavir to ritonavir-indinavir regimen in patients treated with highly active antiretroviral therapy co-infected with hepatitis C is not associated with alteration of liver function tests

AIDS. 2000 Dec 1;14(17):2795-7. doi: 10.1097/00002030-200012010-00024.

Authors

S Vora¹, C Michon, C Junet, J F Balavoine, C Renold-Moynier, S Yerly, L Perrin

Affiliation

¹ Division of Infectious Diseases, Geneva University Hospital, Switzerland.

PMID: 11125903
DOI: 10.1097/00002030-200012010-00024

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Female
Follow-Up Studies
HIV Infections / complications*
HIV Infections / drug therapy*
HIV Infections / immunology
HIV Infections / virology
HIV Protease Inhibitors / administration & dosage
HIV Protease Inhibitors / pharmacology*
HIV Protease Inhibitors / therapeutic use
HIV-1 / drug effects
HIV-1 / physiology
Hepatitis B / complications
Hepatitis B / enzymology
Hepatitis B / physiopathology
Hepatitis B / virology
Hepatitis C / complications*
Hepatitis C / enzymology
Hepatitis C / physiopathology*
Hepatitis C / virology
Humans
Indinavir / administration & dosage
Indinavir / pharmacology*
Indinavir / therapeutic use
Liver Function Tests
Male
Ritonavir / administration & dosage
Ritonavir / pharmacology*
Ritonavir / therapeutic use

Substances

HIV Protease Inhibitors
Indinavir
Ritonavir